Katz Michael David M.D.
- SEC CIK
- 0001919798
No open-market purchases or sales filed in the past year.
Current role at each company
- HNVR Hanover Bancorp, Inc.Directoras of Feb 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Katz Michael David M.D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 (view filing) | Dec 10 | 1 day | Katz Michael David M.D.Director | SSale | −5.00K | $25.53 | −$127.7K | −3.2%149.3K after | |
| Jan 30, 2024 (view filing) | Jan 29 | 1 day | Katz Michael David M.D.Director | PPurchase | +700 | $18.02 | +$12.6K | +0.5%145.1K after | |
| Aug 15, 2022 (view filing) | Aug 11-12 | 4 days | Katz Michael David M.D.Director | PPurchase | +65 | $20.06 | +$1.30K | New position65 after | 2 lots |
| May 11, 2022 (view filing) | May 11 | Same day | Katz Michael David M.D.Director | PPurchase | +5.00K | $21.00 | +$105.0K | +3.6%142.8K after |